Autocrine Motility Factor Signaling Enhances Pancreatic Cancer Metastasis

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Clinical Cancer Research

• Publication date

  2004-11-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/1078-0432.CCR-04-1015PMID 15570012
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cancer Statistics, 2004

  2004cited by this paper
• The hypoxic tumour microenvironment and metastatic progression

  2004cited by this paper
• Molecular-targeted agents in pancreatic cancer.

  2004cited by this paper
• Pancreatic cancer

  2004cited by this paper
• Hypoxia-Inducible Factor 1 Regulates Vascular Endothelial Growth Factor Expression in Human Pancreatic Cancer

  2003cited by this paper
• Regulation of Cell Proliferation by Autocrine Motility Factor/Phosphoglucose Isomerase Signaling*

  2003cited by this paper
• Regulation of colon carcinoma cell invasion by hypoxia-inducible factor 1.

  2003cited by this paper
• Overexpression of the autocrine motility factor/phosphoglucose isomerase induces transformation and survival of NIH-3T3 fibroblasts.

  2003cited by this paper
• Phase II and pharmacodynamic study of the farnesyltransferase inhibitor R115777 as initial therapy in patients with metastatic pancreatic adenocarcinoma.

  2003cited by this paper
• An evidence-based approach to the surgical management of resectable pancreatic adenocarcinoma.

  2003cited by this paper
• Autocrine motility factor secreted by tumor cells upregulates vascular endothelial growth factor receptor (Flt‐1) expression in endothelial cells

  2002cited by this paper
• Inhibition of human cancer cell growth and metastasis in nude mice by oral intake of modified citrus pectin.

  2002cited by this paper
• A double-blind placebo-controlled, randomised study comparing gemcitabine and marimastat with gemcitabine and placebo as first line therapy in patients with advanced pancreatic cancer

  2002cited by this paper
• Hypoxia enhances the expression of autocrine motility factor and the motility of human pancreatic cancer cells

  2002cited by this paper
• Hypoxia-inducible Factor 1 Activation by Aerobic Glycolysis Implicates the Warburg Effect in Carcinogenesis*

  2002cited by this paper
• Tumor Autocrine Motility Factor is an Angiogenic Factor that Stimulates Endotherial Cell Motility.

  2002cited by this paper
• Loss of E-cadherin Expression in Melanoma Cells Involves Up-regulation of the Transcriptional Repressor Snail*

  2001cited by this paper
• Inhibition of growth, invasion, and metastasis of human pancreatic carcinoma cells by NK4 in an orthotopic mouse model.

  2001cited by this paper
• Tumor autocrine motility factor is an angiogenic factor that stimulates endothelial cell motility.

  2001cited by this paper
• Constitutive Sp1 activity is essential for differential constitutive expression of vascular endothelial growth factor in human pancreatic adenocarcinoma.

  2001influential reference
• The transcription factor Snail is a repressor of E-cadherin gene expression in epithelial tumour cells

  2000cited by this paper
• The autocrine motility factor receptor gene encodes a novel type of seven transmembrane protein

  2000cited by this paper
• Pancreatic tumors show high levels of hypoxia.

  2000cited by this paper
• The transcription factor Snail controls epithelial–mesenchymal transitions by repressing E-cadherin expression

  2000cited by this paper
• Deregulation of Glucose Transporter 1 and Glycolytic Gene Expression by c-Myc*

  2000cited by this paper
• The autocrine motility factor receptor gene encodes a novel type of seven transmembrane protein 1

  1999cited by this paper
• Constitutive and inducible interleukin 8 expression by hypoxia and acidosis renders human pancreatic cancer cells more tumorigenic and metastatic.

  1999cited by this paper
• Oncogenic alterations of metabolism.

  1999cited by this paper
• Glucose Uptake and Glycolysis Reduce Hypoxia-induced Apoptosis in Cultured Neonatal Rat Cardiac Myocytes*

  1999cited by this paper
• Expression and secretion of neuroleukin/phosphohexose isomerase/maturation factor as autocrine motility factor by tumor cells.

  1998cited by this paper
• TNM Classification of Malignant Tumors

  1998cited by this paper
• TNM classification of malignant tumours (5 e dition)

  1998cited by this paper
• Inactivation of the E-cadherin-mediated cell adhesion system in human cancers.

  1998cited by this paper
• Autocrine Motility Factor in Pulmonary Adenocarcinomas: Results of an Immunohistochemical Study

  1998cited by this paper
• Role of growth factors in pancreatic cancer.

  1998cited by this paper
• Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.

  1997cited by this paper
• TNM classification of malignant tumors, fifth edition (1997)

  1997cited by this paper
• Abrogation of the Rb/p16 tumor-suppressive pathway in virtually all pancreatic carcinomas.

  1997cited by this paper
• Tumor cell autocrine motility factor is the neuroleukin/phosphohexose isomerase polypeptide.

  1996cited by this paper
• DPC4, A Candidate Tumor Suppressor Gene at Human Chromosome 18q21.1

  1996cited by this paper
• Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism.

  1996cited by this paper
• Autocrine motility factor signals integrin-mediated metastatic melanoma cell adhesion and invasion.

  1996cited by this paper
• Expression of autocrine motility factor receptor in human esophageal squamous cell carcinoma

  1995cited by this paper
• Loss of membranous E‐cadherin expression in pancreatic cancer: Correlation with lymph node metastasis, high grade, and advanced stage

  1994cited by this paper
• Expression of autocrine motility factor receptor in colorectal cancer as a predictor for disease recurrence

  1994cited by this paper
• Cadherins in cancer: implications for invasion and metastasis.

  1993cited by this paper
• Purification of human tumor cell autocrine motility factor and molecular cloning of its receptor.

  1991cited by this paper
• Identification of B16-F1 melanoma autocrine motility-like factor receptor.

  1990cited by this paper
• Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes.

  1988cited by this paper
• The neurotrophic factor neuroleukin is 90% homologous with phosphohexose isomerase

  1988cited by this paper
• Elevated levels of glucose transport and transporter messenger RNA are induced by ras or src oncogenes.

  1987cited by this paper
• The American Joint Committee on Cancer.

  1984cited by this paper
• The detection of hexokinase, glucosephosphate isomerase and phosphoglucomutase activities in polyacrylamide gels after electrophoresis: a novel method using immobilized glucose 6-phosphate dehydrogenase.

  1974cited by this paper
• On the origin of cancer cells.

  1956cited by this paper
• [Origin of cancer cells].

  1956cited by this paper

• The gene expression alterations in chronic hypoxic PANC-1 pancreatic cancer cell line

  2026cites this paper
• Phosphoglucose isomerase directs the inflammatory response, calcium influx and fibroblast migration in keloids

  2026cites this paper
• Four-dimensional trapped ion mobility spectrometry proteomics reveals circulating extracellular vesicles encapsulated drivers of nasopharyngeal carcinoma distant dissemination.

  2024cites this paper
• Proteomic response of A549 lung cancer cell line to protein-polysaccharide complex Venetin-1 isolated from earthworm coelomic fluid

  2023cites this paper
• NUSAP1-LDHA-Glycolysis-Lactate feedforward loop promotes Warburg effect and metastasis in pancreatic ductal adenocarcinoma.

  2023cites this paper
• The Role of Membrane-Associated E3 Ubiquitin Ligases in Cancer

  2022cites this paper
• The significance of glycolysis in tumor progression and its relationship with the tumor microenvironment

  2022cites this paper
• The connection between innervation and metabolic rearrangements in pancreatic cancer through serine

  2022cites this paper
• Enrichment of Prevotella intermedia in human colorectal cancer and its additive effects with Fusobacterium nucleatum on the malignant transformation of colorectal adenomas

  2022cites this paper
• 'Warburg effect' controls tumor growth, bacterial, viral infections and immunity - Genetic deconstruction and therapeutic perspectives.

  2022cites this paper
• Essential role of aerobic glycolysis in epithelial-to-mesenchymal transition during carcinogenesis

  2022cites this paper
• Effects of Metformin Combined With Antifolates on HepG2 Cell Metabolism and Cellular Proliferation

  2022cites this paper
• Interplay Between Glucose Metabolism and Chromatin Modifications in Cancer

  2021cites this paper
• Aberrant lactate dehydrogenase A signaling contributes metabolic signatures in pancreatic cancer

  2021cites this paper
• Tumor microenvironment in chemoresistance, metastasis and immunotherapy of pancreatic cancer.

  2020cites this paper
• Novel N-substituted 5-phosphate-d-arabinonamide derivatives as strong inhibitors of phosphoglucose isomerases: Synthesis, structure-activity relationship and crystallographic studies.

  2020cites this paper
• Proteomic analysis of MYB-regulated secretome identifies functional pathways and biomarkers: potential pathobiological and clinical implications.

  2020cites this paper
• Digging deeper through glucose metabolism and its regulators in cancer and metastasis.

  2020cites this paper
• POLE mutations improve the prognosis of endometrial cancer via regulating cellular metabolism through AMF/AMFR signal transduction

  2019cites this paper
• Electrochemical detection of the human cancer biomarker ‘autocrine motility factor-phosphoglucose isomerase’ based on a biosensor formed with a monosaccharidic inhibitor

  2019cites this paper
• Autocrine motility factor promotes endometrial cancer progression by targeting GPER-1

  2019cites this paper
• Non-canonical roles for metabolic enzymes and intermediates in malignant progression and metastasis

  2019cites this paper
• The enhancement of glycolysis regulates pancreatic cancer metastasis

  2019cites this paper
• Cancer stem cell theory: Are we moving past the mist?

  2019cites this paper
• Higher autocrine motility factor/glucose-6-phosphate isomerase expression is associated with tumorigenesis and poorer prognosis in gastric cancer

  2018cites this paper
• The secreted glycolytic enzyme GPI/AMF stimulates glioblastoma cell migration and invasion in an autocrine fashion but can have anti-proliferative effects

  2018cites this paper
• Up-regulation of Key Glycolysis Proteins in Cancer Development

  2018cites this paper
• Epithelial‐mesenchymal Transition and Cancer Stem Cells: At the Crossroads of Differentiation and Dedifferentiation

  2018cites this paper
• Monoclonal antibodies against autocrine motility factor suppress gastric cancer.

  2017cites this paper
• Carbohydrate-based electrochemical biosensor for detection of a cancer biomarker in human plasma.

  2017cites this paper
• Glucose metabolic phenotype of pancreatic cancer.

  2016cites this paper
• c-Myc targeted regulators of cell metabolism in a transgenic mouse model of papillary lung adenocarcinoma

  2016cites this paper
• Prognostic significance of autocrine motility factor receptor expression by colorectal cancer and lymph node metastases.

  2015cites this paper
• Metabolic changes associated with tumor metastasis, part 1: tumor pH, glycolysis and the pentose phosphate pathway

  2015cites this paper
• Neuroleukin/Autocrine Motility Factor Receptor Pathway Promotes Proliferation of Articular Chondrocytes through Activation of AKT and Smad2/3

  2015cites this paper
• Metabolic regulation of the plasma membrane calcium pump in pancreatic ductal adenocarcinoma

  2015cites this paper
• GPI/AMF inhibition blocks the development of the metastatic phenotype of mature multi-cellular tumor spheroids.

  2014cites this paper
• Generation and Sequencing of Pulmonary Carcinoid Tumor Cell Lines

  2014cites this paper
• The PGI-KLF4 pathway regulates self-renewal of glioma stem cells residing in the mesenchymal niches in human gliomas.

  2014cites this paper
• gp78 is specifically expressed in human prostate cancer rather than normal prostate tissue

  2013cites this paper
• How does cancer cell metabolism affect tumor migration and invasion?

  2013cites this paper
• Prognostic Impact of PHIP Copy Number in Melanoma: Linkage to Ulceration

  2013cites this paper
• Raft endocytosis of AMF regulates mitochondrial dynamics through Rac1 signaling and the Gp78 ubiquitin ligase

  2013cites this paper
• Suppression of AMF/PGI‐mediated tumorigenic activities by ursolic acid in cultured hepatoma cells and in a mouse model

  2012cites this paper
• SIRT1 RNAi knockdown induces apoptosis and senescence, inhibits invasion and enhances chemosensitivity in pancreatic cancer cells

  2011cites this paper
• Targeted Nanogels: A Versatile Platform for Drug Delivery to Tumors

  2011cites this paper
• Differential Responses of Myogenic C2C12 Cells to Hypoxia between Growth and Muscle-Induction Phases : Growth, Differentiation and Motility

  2011cites this paper
• Glucose Metabolism Gene Variants Modulate the Risk of Pancreatic Cancer

  2011cites this paper
• SNAIL induces epithelial-to-mesenchymal transition in a human pancreatic cancer cell line (BxPC3) and promotes distant metastasis and invasiveness in vivo.

  2010cites this paper
• Hypoxia and metastasis in breast cancer.

  2010cites this paper
• Metabolic genes in cancer: their roles in tumor progression and clinical implications.

  2010cites this paper
• Mechanism of Polyubiquitin Chain Recognition by the Human Ubiquitin Conjugating Enzyme Ube2g2*

  2010cites this paper
• Discovery of a set of biomarkers of human lung adenocarcinoma through cell-map proteomics and bioinformatics

  2010cites this paper
• Phosphoglucose Isomerase/Autocrine Motility Factor Promotes Melanoma Cell Migration through ERK Activation Dependent on Autocrine Production of Interleukin-8*

  2009cites this paper
• TrkBT1 induces liver metastasis of pancreatic cancer cells by sequestering Rho GDP dissociation inhibitor and promoting RhoA activation.

  2009cites this paper
• Phosphoglucose isomerase enhances colorectal cancer metastasis.

  2009cites this paper
• The complex biology of autocrine motility factor/phosphoglucose isomerase (AMF/PGI) and its receptor, the gp78/AMFR E3 ubiquitin ligase.

  2009cites this paper
• The tumor microenvironment and metastatic disease

  2008cites this paper
• Transforming Growth Factor-β1 Promotes Matrix Metalloproteinase-9–Mediated Oral Cancer Invasion through Snail Expression

  2008cites this paper
• Hypoxia and Tumour Angiogenesis

  2008cites this paper
• Nanoparticle-mediated drug delivery to tumor vasculature suppresses metastasis

  2008cites this paper
• Raft-Dependent Endocytosis of Autocrine Motility Factor/Phosphoglucose Isomerase: A Potential Drug Delivery Route for Tumor Cells

  2008cites this paper
• Autocrine motility factor receptor: a clinical review

  2008cites this paper
• A new liposomal formulation of Gemcitabine is active in an orthotopic mouse model of pancreatic cancer accessible to bioluminescence imaging

  2008cites this paper
• Hypoxia in cancer cell metabolism and pH regulation.

  2007cites this paper
• Hypoxia-driven selection of the metastatic phenotype

  2007cites this paper
• Down-regulation of phosphoglucose isomerase/autocrine motility factor results in mesenchymal-to-epithelial transition of human lung fibrosarcoma cells.

  2007cites this paper
• Regulation of phosphoglucose isomerase/autocrine motility factor activities by the poly(ADP-ribose) polymerase family-14.

  2007cites this paper
• Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?

  2007cites this paper
• Hypoxia and Metastasis in Breast Cancer

  2007cites this paper
• Oxygen, a source of life and stress

  2007cites this paper
• Expression of snail in pancreatic cancer promotes metastasis and chemoresistance.

  2007cites this paper
• Involvement of an Autocrine Stromal Cell–Derived Factor-1/CXCR4 System on the Distant Metastasis of Human Oral Squamous Cell Carcinoma

  2007cites this paper
• Genes and pathways downstream of telomerase in melanoma metastasis.

  2006cites this paper
• Expression of autocrine motility factor mRNA is a poor prognostic factor in high‐grade astrocytoma

  2006cites this paper
• Expression of Autocrine Motility Factor (AMF) and Its Receptor, AMFR, in Human Breast Cancer

  2006influential citation
• Some more news on the metastatic pathway in pancreatic cancer.

  2005cites this paper
• Expression of Autocrine Motility Factor Correlates with the Angiogenic Phenotype of and Poor Prognosis for Human Gastric Cancer

  2005cites this paper
• The Snail genes as inducers of cell movement and survival: implications in development and cancer

  2005cites this paper